Updates from Lilly about insulin supply and affordability
- As we announced on
March 3, Lillydoes not currently anticipate shortages for any of our medicines, including all forms of insulin. Lilly is committed to manufacturing medicines that meet global safety, quality, value and environmental expectations. With the help of a large network of global external manufacturing partners we supply medication to nearly 125 countries. Lillyis committed to public health and the needs of people with chronic conditions who depend on our medicines around the world.
- Since the initial outbreak,
Lillyhas closely monitored our supply chain for potential impact to the supply of our medicines around the world. We continue to monitor the situation, and our insulin manufacturing sites in the U.S.and Europeremain operational, with increased precautions in place to protect the supply of medicine and the welfare of our employees. Lillydoes not source active pharmaceutical ingredients (API) for any of our approved medicines from China. U.S.pharmacies that temporarily don't have Lillymedicines in stock due to higher demand can order them from wholesalers, and generally they can be delivered in 1 to 2 days. Lillyhas received a few reports of U.S.pharmacies stating that insulin orders are not being fulfilled due to "manufacturer backorder." Lillyhas informed wholesalers and others in the supply chain that we do not have any products on backorder, including insulin. Patients should ask their pharmacist to secure an order from their wholesaler.
- With many individuals financially affected by the COVID-19 crisis,
Lillywants to remind people of cost-saving options for insulin, especially for those with no or limited income. Anyone who has lost employment and uses Lillyinsulin should call the LillyDiabetes Solution Center at (833) 808-1234 to learn about options that include access to free insulin that has been donated for people with lower incomes. For people with an urgent need for insulin and nowhere else to turn, the Solution Center can help provide immediate help. The Solution Center is open 9 am to 8 pm ET Monday through Friday.
"COVID-19 is an unprecedented challenge for all of us, but
Approximately 34 million Americans1 (just over 1 in 10) and an estimated 463 million adults worldwide2 have diabetes. Type 2 diabetes is the most common type internationally, accounting for an estimated 90 to 95 percent of all diabetes cases in
This release contains forward-looking statements regarding product supply, assistance for people living with diabetes, and COVID-19. These statements are based on management's current expectations, but actual results may differ materially. Other risk factors that may affect the company's results can be found in the company's latest Forms 10-K and 10-Q filed with the
1 Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2020.
2 International Diabetes Federation. IDF Diabetes Atlas, 9th edn.
View original content to download multimedia:http://www.prnewswire.com/news-releases/updates-from-lilly-about-insulin-supply-and-affordability-301028654.html